Complications following Permanent Filler Injection: A Prospective Cohort Study and Protocol of Management.

Autor:	Mortada H; Division of Plastic Surgery, Department of Surgery, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.; Department of Plastic Surgery and Burn Unit, King Saud Medical City, Riyadh, Saudi Arabia., Al Saud N; Department of Plastic Surgery and Burn Unit, King Saud Medical City, Riyadh, Saudi Arabia., Alaithan B; Plastic Surgery Division, Surgery Department, King Fahad Medical City, Riyadh, Saudi Arabia., Alhumsi T; Department of Plastic Surgery and Burn Unit, King Saud Medical City, Riyadh, Saudi Arabia.
Jazyk:	angličtina
Zdroj:	Plastic and reconstructive surgery. Global open [Plast Reconstr Surg Glob Open] 2022 Nov 28; Vol. 10 (11), pp. e4687. Date of Electronic Publication: 2022 Nov 28 (Print Publication: 2022).
DOI:	10.1097/GOX.0000000000004687
Abstrakt:	Permanent filler (PF) substances are increasingly utilized in aesthetic procedures. Concurrently, complications related to fillers have also risen. This study aims to determine the rate of complications secondary to PF injections and develop a therapeutic approach for treating such complications. Methods: This cohort study was conducted by distributing a checklist form among all patients aged 18 years or older who arrived for a new cosmetic consultation between 2015 and 2019. The primary outcome was the occurrence of complications, which are defined as symptoms induced by the PF. The demographics, type of PF, injection site, the time for the complication to occur, and signs and symptoms were recorded and followed up. Results: In this study, 325 out of 503 (64.61%) patients presented with PF-related complications. About 92.8% were women. All patients with PF-related complications presented with a lump (n = 325, 100%). In regard to the anatomical area of injection, the most common areas were the cheeks (66.6%). The time it took for the complication to occur most commonly ranged from 1-5 years (39.2%, P < 0.001). Complications were significantly higher among patients who received the injection in a nonmedical facility ( P < 0.0002). Seventy-seven cases (15.3%, P < 0.0001) underwent PF removal. Conclusions: PF-related complications in the body exhibit a wide range of onset and adverse events. The best method to prevent complications caused by permanent filling materials is to avoid them altogether. When it comes to permanent filling agents, we suggest extreme caution. (Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu